Abiopharma

🔍 Kinlaw Sheryl L (Executive)

Company: CITIZENS, INC. (CIA)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 5,128 shares of Citizens, Inc. Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 94,142.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,249 shares of Citizens, Inc. Class A Common Stock at $5.03 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 92,893.00 | transaction_form_type: 4
• Acquired 8,536 shares of Citizens, Inc. Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 101,429.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,079 shares of Citizens, Inc. Class A Common Stock at $5.03 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 99,350.00 | transaction_form_type: 4
• Sold 5,128 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,256.00 | transaction_form_type: 4 | Footnotes: F3, F1, F1
• Sold 8,536 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F2, F2
• Acquired 13,916 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,916.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
• Holds 15,174 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 15,174.00 | Footnotes: F3, F5, F5
• Holds 10,904 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 10,904.00 | Footnotes: F3, F6, F6

Footnotes:

• F1: On March 31, 2025, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2025 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2026) an dthe second anniversary of the date of the grant (March 31, 2027) and the third anniversary of the date of the grant (March 31, 2028).
• F2: On March 31, 2023, the reporting person was granted an award of restricted stock units, vesting in three equal annual installments on the first anniversary of the date of the grant (March 31, 2024) and the second anniversary of the date of the grant (March 31, 2025) and the third anniversary of the date of the grant (March 31, 2026).
• F3: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock.
• F4: On March 31, 2026, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2026 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2027) an dthe second anniversary of the date of the grant (March 31, 2028) and the third anniversary of the date of the grant (March 31, 2029).
• F5: On March 28, 2024, the reporting person was granted an award of restricted stock units (RSUs) under the Citizens, Inc. Omnibus Incentive Plan for 2023 pay-for-performance. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 28, 2025) and the second anniversary of the date of the grant (March 28, 2026) and the third anniversary of the date of the grant (March 28, 2027).
• F6: On March 28, 2024, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2024 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 28, 2025) and the second anniversary of the date of the grant (March 28, 2026) and the third anniversary of the date of the grant (March 28, 2027).